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De-Gendering Health Insurance: A Case for a 
Federal Insurance Gender Nondiscrimination Act 
Kate Walsham* 
I. INTRODUCTION 
The Patient Protection and Affordable Care Act (ACA) is the most 
sweeping change to healthcare in the United States since Medicare was 
passed in 1965.1  The ACA also creates the perfect platform from which to 
improve access to medical care for transgender people2 by securing explicit 
protections for gender-confirming3 and gender-incongruent4 procedures 
while simultaneously being pragmatic and increasing efficiency.  The exact 
 
*Editor-in-Chief, 2012-2013, Hastings Women’s Law Journal; J.D. Candidate, 2013, 
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2007. Many thanks to: the members of HWLJ; Professor Elizabeth L. Hillman for her 
invaluable guidance throughout writing this note; Matt Wood at the Transgender Law 
Center for providing redacted letters denying trans people care, for reading an early draft, 
and for his encouragement and feedback; and, Jack Lathe for being continually supportive 
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 1. David Leonhardt, In Health Bill, Obama Attacks Wealth Inequality, N.Y. TIMES, Mar. 
24, 2010, at A1; see also The Patient Protection and Affordable Care Act of 2010, Pub. L. 
No. 111–148, 124 Stat. 119 (codified as amended in scattered sections of 42 U.S.C., 26 
U.S.C., 31 U.S.C., 30 U.S.C., 21 U.S.C., 29 U.S.C., 20 U.S.C.) [hereinafter ACA]. 
 2. “Transgender” or “trans” are terms used throughout this note to describe people who 
express their gender differently than what is traditionally associated with the sex they were 
assigned at birth.  “Transsexual” refers to a procedure that is considered one that changes a 
person’s sex, or refers to a person who has undergone such a procedure.  The term 
“transman” refers to a person who was assigned female at birth but who identifies as a man.  
Conversely, “transwoman” refers to a person assigned male at birth but who identifies as a 
woman.  Transgender people may or may not choose to physically alter their bodies to 
reflect their gender identity.  For a thorough discussion of some definitions of these terms 
and their history and the medicalization of those identities, see Dean Spade, Documenting 
Gender, 59 HASTINGS L.J. 731, n.12 (2008) [hereinafter Spade, Documenting]; see also, 
generally Dean Spade, Resisting Medicine, Re/Modeling Gender, 11 BERKELEY WOMEN’S 
L.J. 15 (2003) [herinafter Spade, Resisting] (describing trans people’s interactions with the 
U.S. medical system). 
 3. “Gender-confirming care” refers to any procedures that help a transgender person 
realize their authentic gender. These might include hormone treatment or sexual 
reassignment surgery (SRS) or both.  Insurance Gender Nondiscrimination Act Analysis 
of Assembly Bill 1586, Hearing Before S. Comm. on Banking, Finance, & Ins., 2005-2006 
Regular Session (Cal. 2005), available at ftp://leginfo.public.ca.gov/pub/05-06/bill/asm/ab_ 
1551-1600/ab_1586_cfa_20050613_175230_sen_comm.html [hereinafter A.B. 1586 Analysis]. 
 4. Gender-incongruent procedures are procedures typically required by people who have 
a different gender marker.  Id; see also infra Part II.B.2. 
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number of transgender people in the United States is unknown, but it is 
estimated to be between one and three percent of the adult population.5  We 
can estimate that there are between three million and nine million 
transgender Americans.6  Transgender people therefore represent a 
significant number of people whose healthcare access and outcomes should 
be accounted for in national legislation. 
In 2005, California enacted a first-of-its-kind bill to ensure insurance 
protections for transgender Californians.7  The Insurance Gender 
Nondiscrimination Act (IGNA),8 which prohibits discrimination on the 
basis of gender and gender identity in insurance coverage, should be the 
model for the states and for federal regulations as the ACA’s provisions go 
into effect.  Adding a version of the IGNA to the ACA would be a cost-
effective means of making healthcare more accessible for the transgender 
community, a particularly vulnerable group of Americans. 
This note advocates for enactment of a federal Insurance Gender 
Nondiscrimination Act based on California’s bill and the California 
Department of Insurance (CDI) regulations regarding enforcement of the 
IGNA.  Part II briefly contextualizes the current problem transgender 
people face in accessing healthcare.  It describes the history of transgender 
exclusions in both public and private insurance, and explores the scheme of 
insurance coding which informs whether or not a procedure is considered 
“transsexually related” and therefore excluded.  It also describes individual 
instances of exclusions for gender-confirming treatment or gender-
incongruent procedures.  Part III explores California’s IGNA in detail, 
addressing the IGNA’s shortcomings and CDI’s new enforcement 
regulations, enacted August 3, 2012, and effective as of September 2, 2012.  
Part IV analyzes the provisions of the ACA as they may apply to 
transgender people.  First, it briefly describes the ACA’s scope and its 
shortcomings as they relate to trans people’s access to care, then it 
describes how cost-shifting changes brought about by the ACA’s reforms 
will be affected by trans-inclusive policies.  Part V addresses concerns that 
 
 5. Kari E. Hong, Categorical Exclusions: Exploring Legal Responses to Health Care 
Discrimination Against Transsexuals, 11 COLUM. J. GENDER & L. 88, 91 (2002) (quoting 
JAMISON GREEN & LARRY BRINKIN, S.F. HUMAN RIGHTS COMM’N, INVESTIGATION INTO 
DISCRIMINATION AGAINST TRANSGENDERED PEOPLE 9  (1994)). 
 6. There are approximately 314 million people in the United States.  US PopClock 
Projection, U.S. CENSUS BUREAU, (Sept. 23, 2012), http://www.census.gov/population/www 
/popclockus.html. 
 7. Insurance Gender Nondiscrimination Act, 2005 Cal. Legis. Serv. 421 (West) 
[hereinafter A.B. 1586]. 
 8. CAL. HEALTH & SAFETY CODE § 1365.5(a) (2005); CAL. INS. CODE § 10140(a) (2005).  
California’s health insurance regulation statutes are bifurcated into the Health and Safety 
code and the Insurance code.  The IGNA appears in both section 1365.5 of the California 
Health and Safety code and section 10140 of the California Insurance code—these 
provisions are identical.  For simplicity, throughout this note, “A.B. 1586” and “IGNA” 
refer to both California code provisions.  Where it is relevant, specific code sections are 
referenced. 
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covering sex reassignment surgery (SRS) and gender-confirming care 
would increase insurance cost beyond the reasonable risk absorption for the 
transgender population, and concludes that cost concerns are insufficient to 
warrant continued exclusions for transgender care. 
II. CONTEXT: A BRIEF HISTORY OF TRANSGENDER 
HEALTHCARE AND THE EXISTING PROBLEM OF 
ACCESSING CARE 
The health insurance industry considers transgender people to be an 
insurance risk.9  Because insurance generally exists to protect against the 
unexpected, an existing condition is not deemed an insurable risk because it 
is known.10  Health insurance and healthcare provisions exist in an 
increasingly regulated market.11  This regulation limits the ways in which 
health insurance is able to rely on standard market forces because 
regulations prevent insurers from excluding certain types of risk from their 
insurance pools.12  The likelihood of an event’s occurrence brackets the 
coverage limits of “risk spreading” insurance like fire or earthquake 
insurance, but in healthcare, there are other limitations on coverage.13  The 
metric in market reliance for determining whether to cover a benefit for one 
individual in the insurance pool is the overall benefit of expenditure for the 
insured group—meaning that care or services will only be covered if it is 
generally beneficial for the entire group for one of its members to receive 
treatment.14  In health insurance, regulations require insurers to take on 
more risk than market forces would otherwise allow.15  For example, the 
Americans with Disabilities Act (ADA) prevents discrimination in 
employment on the basis of disability.16  Employers with health insurance 
benefits for their employees therefore cannot ask potential employees to 
submit to a physical exam prior to committing to hiring and insuring that 
 
 9. Liza Khan, Note, Transgender Health Insurance at a Crossroads: Legal Norms, 
Insurance Markets, and the Threat of Healthcare Reform, 11 YALE J. HEALTH POL’Y L. & 
ETHICS 375, 386–410 (2011).  
 10. Id. at 389. 
 11. Id.; see also, generally ACA, supra note 1. 
 12. Khan, supra note 9, at 389–90. 
 13. Wendy K. Mariner, Health Reform: What’s Insurance Got to Do with It? Recognizing 
Health Insurance as a Separate Species of Insurance, 36 AM. J.L. & MED. 436, 438 (2010) 
(“[I]t is possible to reconcile these conceptions if we recognize health insurance as a 
separate species of insurance[—]distinct in function, and therefore content, from 
conventional indemnity insurance models.  Both regulation and industry practices already 
have moved health insurance a long way toward becoming an identifiably separate species 
by limiting some risk classification methods, but universal coverage requires purging or 
greatly circumscribing most tools of conventional insurance.”). 
 14. Khan, supra note 9, at n.77. 
 15. Khan, supra note 9, at 389–90. 
 16. 42 U.S.C.A. § 12112 (West 2009). 
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person.17  The ADA, therefore, increases the risks that health insurers are 
required to take on.18 
Treatment for transgender people has been traditionally excluded from 
risk sharing frameworks in both public and private insurance.  Treatment 
exclusion is partially tied to the ADA,19  which is relevant for two reasons.  
First, it explicitly excludes transsexualism from the definition of 
disability.20  This exclusion allows discrimination towards trans people in 
public insurance.21  Second, the public accommodations provisions of the 
ADA do not reach insurance contents.22  This means that the ADA allows 
for diagnosis and treatment exclusions in insurance generally.  For 
example, HIV is often an excluded diagnosis, meaning that people 
diagnosed with HIV will not have their medication covered by insurance 
even though HIV is considered a disability under the ADA.23 
In public insurance, “[t]he Medicaid agency may not arbitrarily deny or 
reduce the amount, duration, or scope of a required service . . . to an 
otherwise eligible recipient solely because of the diagnosis, type of illness, 
or condition.”24  If a procedure is determined to be medically necessary, 
Medicaid will cover that procedure.25  “Thus, coverage of sex-reassignment 
surgery under Medicaid turns on each state’s determination of whether or 
not the procedure is medically necessary” for the patient.26  Some states 
have found that Medicare should cover SRS on a case-by-case basis when 
medically necessary, while other states have not.27 
 
 17. 42 U.S.C.A. § 12201 (West 2012). 
 18. R. Nick Gorton, Transgender Health Benefits: Collateral Damage in the Resolution 
of the National Health Care Financing Dilemma, 4 SEXUALITY RES. & SOC. POL’Y J. OF 
NAT’L SEXUALITY RES. CTR. 81, 81–85 (2007).  
 19. 42 U.S.C.A. § 12211 (West 2009). 
 20. “[T]he term ‘disability’ shall not include transvestism, transsexualism, pedophilia, 
exhibitionism, voyeurism, gender identity disorders not resulting from physical 
impairments, or other sexual behavior disorders.”  42 U.S.C.A. § 12211.  This definition 
goes on to list “compulsive gambling, kleptomania, or pyromania [, and] psychoactive 
substance use disorders resulting from current illegal use of drugs” as other conditions 
excluded by the ADA.  For a more in depth analysis of the ramifications of these exclusions, 
see generally Hong, supra note 5. 
 21. See generally Hong, supra note 5 (discussing categorical exclusions in health 
insurance). 
 22. Sara Rosenbaum, Insurance Discrimination on the Basis of Health Status: An 
Overview of Discrimination Practices, Federal Law, and Federal Reform Options, 37 J.L. 
MED. & ETHICS 103, 109 (2009). 
 23. Id. at 107. 
 24. 42 C.F.R. § 440.230(b) (2011). 
 25. Id. 
 26. Jerry L. Dasti, Advocating a Broader Understanding of the Necessity of Sex-
Reassignment Surgery Under Medicaid, 77 N.Y.U. L. REV. 1738, 1757 (2002). 
 27. See, e.g., Pinneke v. Preisser, 623 F.2d 546, 549 (8th Cir. 1980) (holding Iowa’s 
policy of denying Medicaid benefits for sex reassignment surgery to be “an arbitrary denial 
of benefits based solely on the ‘diagnosis, type of illness, or condition.’”); Smith v. 
Rasmussen, 249 F.3d 755 (8th Cir. 2001) (holding Medicaid confers broad discretion on the 
States to adopt their own standards and that Iowa’s decision not to cover Smith’s 
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Insurers are able to restrict access to certain procedures and for certain 
diagnoses because the ADA does not prohibit limitations in insurance 
coverage based on specific actuarial risk that is also not prohibited under 
state law.28  “Thus, private health insurers can single out certain conditions 
(e.g., HIV/AIDS) for complete or near-total coverage exclusion, so long as 
the exclusion applies to all plan members.”29  Despite the fact that these 
exclusions appear to be discriminatory, and “despite rulings by the federal 
agencies to the contrary, courts have deferred to the concepts of actuarial 
fairness and risk classification, even where actuarial justification is 
absent.”30  These rulings do not take into account the fact that the ADA’s 
insurance safe harbor only permits treatment and diagnosis exclusions 
where they are actuarially justified.31  Because transsexualism is 
specifically excluded from the ADA, actuarially unsound practices are 
insufficient to show that gender-confirming procedures should be covered, 
and “obtaining federal protections through the ADA involves convincing 
courts not only that gender identity disorder is a legitimate illness needing 
treatment but also that the exclusion within the law itself is 
unconstitutional.”32  It is within this framework that insurance companies 
have had the leeway to exclude coverage for transgender people.33 
Transgender people face a number of difficulties accessing gender-
confirming care when they are insured.  Insurance companies routinely 
classify transgender status as a preexisting condition exempt from 
treatment, or classify gender-confirming treatments as cosmetic or elective 
because they seek to change anatomy that is considered normal and 
functional.34  These classifications place transgender insureds seeking 
gender-confirming care in a bureaucratic limbo in which doctors recognize 
that gender-confirming care is a necessary medical procedure for 
transgender patients, but insurance companies generally refuse to cover 
transition-related care.35  The “AMA supports public and private health 
 
phalloplasty was within that discretion); G.B. v. Lackner, 80 Cal. App. 3d 64 (1978) 
(holding MediCal coverage could not be denied for a transgender woman’s SRS where her 
doctor determined it was medically necessary). 
 28. 42 U.S.C.A. § 12201 (West 2009). 
 29. Rosenbaum, supra note 22, at 109. 
 30. Id. 
 31. Id. 
 32. Gorton, supra note 18, at 84.  
 33. “Exclusions” in this section refer both to explicit contractual provisions in various 
health plans which state that certain benefits are excluded from coverage and to the effect of 
receiving a denial of coverage even if a benefit is not in fact listed under the “exclusions” 
section of a health plan. 
 34. Khan, supra note 9, at 390–99; but see Lackner, 80 Cal. App. 3d at 70 (finding 
castration and penectomy did not qualify as cosmetic surgery defined by Medi-Cal as 
surgery having the purpose of “alter[ing] the texture and configuration of the skin and the 
skin’s relationship with contiguous structures of the body,” and holding that Medi-Cal must 
provide coverage for medically necessary SRS). 
 35. Khan, supra note 9, at 391, n.79.  
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insurance coverage for treatment of gender identity disorder as 
recommended by the patient’s physician” and “opposes the denial of health 
insurance on the basis of . . . gender identity.”36  Insurance companies, on 
the other hand, do not see providing gender-confirming care to be essential, 
or generally beneficial to the groups they insure.37  Another difficulty with 
re-classifying gender-confirming care as medically necessary is that 
procedures that are often classified as elective or cosmetic surgeries for 
nontrans patients, such as facial feminization surgery or breast 
augmentation, can be medically necessary for trans patients.38  This creates 
a perverse incentive for medical providers to ban all such surgeries because 
a ban limits insurance liability. 
A.  MEDICAL CODING AND THE ICD-9 
Classifying SRS and gender-confirming care as nonessential medical 
care is not effective for limiting access to these procedures if doctors 
working with transgender patients use diagnostic and treatment codes that 
obfuscate their patients’ transgender status.  The current scheme of medical 
coding includes a system of diagnostic and procedure codes known as the 
ICD-9.39  These codes specify every conceivable ailment for each piece of 
anatomy and allow doctors to specify what treatment they plan to provide 
for that ailment.40  Because the ICD-9 includes so much information, in 
many cases there are multiple codes that will achieve the same objective 
for a patient by classifying the same treatment differently.41 
Transgender people seeking gender-confirming care are routinely 
denied when their care is coded as transsexual-related care.42  The 
following ICD-9 diagnostic codes: 302.51, trans-sexualism with asexual 
history; 302.52, trans-sexualism with homosexual history; 302.53, trans-
sexualism with heterosexual history; 302.6, GID in children; and, 302.85, 
GID of adolescence or adult life are often denied because these codes are 
directly related to and expressly prohibited by many insurance plans’ 
 
 36. AMA Policies on GLBT Issues, Patient Centered Policies at H-185.950, H-180.980,  
AM. MED. ASS’N, http://www.ama-assn.org/ama/pub/about-ama/our-people/member-groups-
sections/glbt-advisory-committee/ama-policy-regarding-sexual-orientation.page# (last visited 
Feb. 10, 2012). 
 37. Gorton, supra note 18, at 85. 
 38. Khan, supra note 9, at 394–95. 
 39. Classifications: International Classification of Disease (ICD), World Health Org., 
http://www.who.int/classifications/icd/en/ (last visited Feb. 27, 2012).  The ICD-10 has been 
available and used by other countries for the last fifteen years but U.S. insurers have not yet 
adopted it. Tom Sullivan, 5 Lessons the U.S. Can Learn from Other Countries' ICD-10 
Moves, ICD-10 WATCH (Mar. 01, 2010, 10:52 AM), http://www.icd10watch.com/blog/5-
lessons-us-can-learn-other-countries-icd-10-moves.   
 40. 2009 ICD-9-CM: Diseases and Injuries Tabular Index, http://icd9cm.chrisendres. 
com/ (last visited Mar. 2, 2012). 
 41. Id. 
 42. PROJECT HEALTH, CODING FOR TRANSITION-RELATED SERVICES FOR TRANSGENDER 
PATIENTS (2012) (on file with author).  
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transsexual treatment exclusion provisions.43  ICD-9 codes which are not 
routinely denied as being transsexual treatment include: 259.9, unspecified 
endocrine disorder; 257.2, other testicular hypofunction; 256.39, other 
ovarian failure; 752.7, indeterminate sex and pseudohermaphrodism; 
V58.69, long-term (current) use of other medications; and, 611.1, 
hypertrophy of breast.44  By carefully choosing insurance-covered 
diagnostic codes that accurately reflect their patients’ medical conditions, 
doctors have been able to find ways for their trans patients to receive 
gender-confirming care even in the face of explicit exclusions for 
transsexual care.45  By carefully coding their trans patients’ care, some 
doctors appear to recognize the existing trans exclusions in insurance 
policies are improper status discrimination. 
Coding schemes are also connected with the software that governs 
insurance companies’ determinations of whether or not a plan will cover 
the cost of a coded procedure.46  In this process, the doctor’s chosen ICD-9 
codes will indicate the treatment and the diagnosis necessitating that 
treatment.47  When a claim requesting coverage for a treatment/diagnosis 
combination goes to the insurance company, the insurer’s claims process 
will check whether the patient’s insurance plan ever covers the procedure, 
whether the procedure is appropriate for the diagnosis, whether the 
diagnosis is appropriate for the person based on gender among other 
factors, and whether the patient’s history or other factors including gender 
and age comport with the provider’s understanding of the circumstances 
when the insurer offers coverage.48 
B.  EXCLUSION OF MEDICALLY NECESSARY PROCEDURES AND 
COUNTERINTUITIVE DENIALS  
Medically necessary procedures include both gender-confirming care 
procedures and gender-incongruent procedures.  Transgender patients’ 
experiences with being denied care for each of these types of treatments 
illustrate the harm that results from treatment failures.  As these stories 
show, both the patients and the insurance companies suffer from an 
inefficient and problematic system. 
 
 43. PROJECT HEALTH, supra note 42. 
 44. Id.; but see Clinical Policy Bulletin: Gender Reassignment Surgery, AETNA, 
http://www.aetna.com/cpb/medical/data/600_699/0615.html (last visited Oct. 11, 2011) 
(denying coverage for SRS where nontransgender-specific ICD-9 Code is used). 
 45. PROJECT HEALTH, supra note 42. 
 46. Telephone Interview with Christina Diaz, Customer Serv. Representative, Blue 
Shield of Cal. (Mar. 2, 2012); E-mail from Anonymous, Software Engineer, Epic Sys. to 
author (Dec. 9, 2011). 
 47. Telephone Interview with Christina Diaz, supra note 46; E-mail from Barbara 
Hernandez, Corporate Spokesperson, Epic Sys. to author (Mar. 2, 2012) (claiming 
diagnosis/treatment analysis and coding process as proprietary information). 
 48. Telephone Interview with Christina Diaz, supra note 46. 
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1. Gender-Confirming Care Procedures  
One transman (A) lives in a jurisdiction that does not require proof of 
surgery to correct his identity documents.49  He was therefore able to obtain 
a driver’s license and other ID with the appropriate gender marker and 
name without ever having surgery.50  Some years after he had corrected his 
ID, he sought a double mastectomy both because he desired it as gender-
confirming care, and because there was a history of breast cancer in his 
family for which the procedure would serve as prophylaxis.51  If he had 
applied for a double mastectomy before his paperwork had been corrected, 
he would have been applying for a “female” procedure as a person with 
“female” documents.  As it was, his documents indicated that a mastectomy 
would be a gender-incongruent procedure and was therefore not covered.52  
He explains: “[I] could have gotten it covered as preventative mastectomy, 
because my grandfather died of breast cancer in his 50’s [sic].  But because 
I’d changed my ID years ago, no surgery for me, even though my family 
history of breast cancer was specifically male.”53  This is exactly the sort of 
bureaucratic absurdity that burdens both transgender patients and the 
healthcare system generally.54  This man’s double mastectomy served two 
medically sound purposes.  First, it functioned as well-established 
preventative care for breast cancer.55  Second, it was appropriate treatment 
for his GID.  However, because his plan excluded any transition-related 
surgical procedures, a procedure that served both a transition-related 
purpose and a cancer-preventative purpose was not covered.56  A gender 
congruency check on A’s doctor’s order showed a mismatch for a 
mastectomy since men are not approved for breast cancer preventative 
 
 49. Tgjer, Comment to Law Student Looking for Letters Denying Insurance Coverage to 
Trans People, REDDIT, http://www.reddit.com/r/asktransgender/comments/nelnq/law_student 
_looking_for_letters_denying_insurance/c38isbt (last visited Feb. 20, 2012). 
 50. Id. 
 51. Id. 
 52. Id. 
 53. Id.  
 54. A double mastectomy would cost the insurance company approximately $7,600 as a 
preventive measure.  If the mastectomy were due to cancer, it would cost $1,000 for a 
biopsy showing cancer, $7,600 for the surgery, and potentially $11,000 or more in radiation 
and/or chemotherapy treatments.  See Healthcare Blue Book: Your Free Guide to 
Healthcare Pricing, CAREOPERATIVE, http://healthcarebluebook.com (last visited Feb. 10, 
2012). 
 55. Preventive Mastectomy, NAT’L CANCER INST., http://www.cancer.gov/cancertopics/ 
factsheet/Therapy/preventive-mastectomy (last visited Feb. 19, 2012) (“Preventive 
mastectomy may be an option for a woman whose mother, sister, or daughter had breast 
cancer, especially if they were diagnosed before age 50 [sic].  If multiple family members 
have breast or ovarian cancer, then a woman’s risk of breast cancer may be even higher.”). 
The risk factor for the preventative treatment is gender neutral “family member,” 
nonetheless the risk of cancer is only considered for women.  Id. 
 56. Tgjer, supra note 49.  
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treatment because their risk factors do not make that treatment reasonable 
for insurers to take on.57 
Another transman (B) whose insurance plan classified him with a 
female gender marker was also denied coverage for a double mastectomy.58  
A letter he received from his insurance company indicated a procedure 
code of 19303,59 defined as a “Simple Complete Mastectomy” procedure, 
which “includes removal of all breast tissue, along with a portion of skin 
and nipple through an elliptical incision.”60  This is a standard procedure 
and there is no indication based on the code itself that it is trans specific.61  
B was denied coverage for his mastectomy because his doctor’s notes or 
the diagnostic code accompanying the treatment request indicated that the 
procedure would treat his gender identity disorder, and/or because he did 
not meet his insurer’s standards for preventive mastectomy.62 
A transwoman (C) was receiving estrogen therapy, which was covered 
by her insurer.63  Her doctors prescribed an unusually high dosage of 
estrogen to counteract her body’s unusually high production of 
testosterone.64  The unusually high doses of estrogen exposed her to an 
increased risk of stroke and other complications.65  Her doctors 
“determined that this [risk] was not a safe or sustainable situation and 
recommended that she undergo an orchiectomy (removal of testicles).”66  
Despite this procedure being a medically necessary, preventive treatment, 
she was denied coverage for the surgery on the basis of an express 
exclusion for transgender surgery in her plan.67  This plan originated in 
California; therefore exclusion was unlawful under the IGNA.  However, 
without explanation, the California Department of Managed Health Care 
(DMHC) did not enforce the law to override the policy’s express 
exclusion.68 
2. General Preventative Care and Treatment 
Transgender people are routinely denied coverage for basic care when 
their care would typically be covered, or even mandated, for a person 
 
 57. See supra text accompanying notes 46–49. 
 58. Letter from HMO to B (Apr. 5, 2011) (on file with author). 
 59. Id. 
 60. Coding Breast Diseases and Surgery, Part 2, ADVANCE FOR HEALTH INFO. 
PROFESSIONALS (Apr. 23, 2007), http://health-information.advanceweb.com/Article/Coding-
Breast-Diseases-and-Surgery-Part-2.aspx. 
 61. See supra text accompanying notes 46–49. 
 62. See supra note 55. 
 63. Shannon Minter et al., A New Approach to Healthcare Equality for Transgender 
People: California’s Insurance Gender Non-Discrimination Act, 2 LGBTQ POL’Y J.  HARV. 
KENNEDY SCH. 35, 39 (2012). 
 64. Id. at 40. 
 65. Id. 
 66. Id. 
 67. Id.  
 68. Id. at 41.  
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whose gender marker and physiology are congruent.69  Procedures typically 
required by people with a different gender marker are known as “gender 
incongruent procedures.”  D, for example, was informed that his claim for a 
pap smear “will not be covered if the diagnosis and/or procedure codes are 
for female procedures” after his gender marker has been changed to male.70  
E was denied coverage for a bone density scan.71  He had a family history 
of osteoporosis.72  He was over fifty, which was within the appropriate age 
for a woman with his medical and family history to receive a bone density 
scan.73  But, E had updated his gender marker to reflect his male gender 
identity.  Without any change in his risk factors, E’s male gender marker 
was sufficient to bar coverage of a medically necessary scan.74  E appealed 
his denial to the DMHC and because of California’s IGNA, DMHC 
reversed the denial.75 
Robert Eads, a transman, and the subject of the 2001 documentary 
Southern Comfort, was diagnosed with ovarian cancer in 1996.76  With that 
diagnosis he sought treatment from dozens of doctors, each of whom 
turned him away for fear that treating a transgender patient would harm 
their practices.77  By the time he was able to find a hospital willing to treat 
him in 1998, his cancer had metastasized and despite aggressive treatment 
he died at the age of fifty-three.78 
III. CALIFORNIA INSURANCE GENDER 
NONDISCRIMINATION ACT—A.B. 1586 
In 2005, California became the only state thus far to recognize and 
address the persistent problem transgender people face accessing care even 
when they have insurance that would cover the care by enacting A.B. 1586, 
the IGNA.79  The state recognized the issue by stating that while 
transgender insureds “may identify themselves as a certain sex, they may 
still need medical services typically given to members of the opposite sex. 
 . . . A health plan that automatically denies coverage of gynecological 
services for men as inappropriate could then deny appropriate and 
medically necessary services for transgender enrollees.”80  The IGNA 
thereby establishes an “equality framework” for insurance in California 
 
 69. CAL. CODE REGS. tit. 10 §§ 2561.1, 2561.2 (2012). 
 70. Letter from HMO to D (Oct. 24, 2007) (on file with author). 
 71. Letter from HMO to E (May 19, 2010) (on file with the Transgender Law Center). 
 72. Id. 
 73. Letter from HMO to E (Jan. 26, 2011) (on file with the Transgender Law Center). 
 74. Letter from HMO to E (May 19, 2010), supra note 71. 
 75. Letter from HMO to E (Jan. 26, 2011), supra note 73. 
 76. SOUTHERN COMFORT (Q-Ball Productions 2001). 
 77. Id. 
 78. Id. 
 79. Minter, supra note 63, at 37; A.B. 1586 Analysis, supra note 3; A.B. 1586, supra note 7. 
 80. A.B. 1586 Analysis, supra note 3. 
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where if an insurer covers a procedure for a nontransgender patient, it must 
cover that procedure for a transgender patient.81 
A.  IGNA ELIMINATES GENDER AS LEGITIMATE BASIS FOR DENYING 
CARE  
The IGNA does not mandate that a plan cover any particular type of 
benefit, procedure, or treatment.82  But it does require that if a plan 
provides a particular benefit, procedure, or treatment for a nontransgender 
person, it must do so for a transgender person as well.83  The bill sought to 
address problems such as “charging higher premiums without sound 
actuarial justification; refusal to cover medically necessary treatments, 
including gender-specific treatments . . . that would be covered for other 
people; and refusal to cover treatments related to gender transition when 
the same treatments are covered for other conditions.”84  For example, if 
pap smears are covered by the insurance plan generally, the fact that a 
person’s gender marker is male cannot prevent him from receiving 
insurance coverage for his pap smear.85  By requiring that the same care be 
made available to all insurance plans’ enrollees, A.B. 1586 invalidated a 
discriminatory scheme from insurance companies’ plan administration.86 
B.  CALIFORNIA DEPARTMENT OF INSURANCE: NEW REGULATIONS ARE 
INSTRUCTIVE 
California insurance is regulated by two different systems of laws, each 
of which is regulated by its own agency.87  The Knox-Keene Act regulates 
HMO insurance and is enforced by the DMHC.88  The California insurance 
code regulates PPO insurance and is enforced by the CDI.89  Each 
regulatory agency has discretion in its enforcement of the IGNA.90  For a 
variety of reasons that include a lack of knowledge on the part of both 
patients and providers about the new law’s protections, prohibitions, and 
requirements, and inconsistent enforcement by administrative agencies, the 
IGNA has not been especially effective since being adopted in 2005.91  In 
 
 81. Minter, supra note 63, at 37.  
 82. A.B. 1586, supra note 7, at § 3. 
 83. Id.; Minter, supra note 63, at 38. 
 84. Minter, supra note 63, at 37. 
 85. CAL. CODE REGS. tit. 10 § 2561.2 (2012).  
 86. Minter, supra note 63, at 37–38. 
 87. Laws Relating to Health Care Plans in California, DEP’T OF MANAGED HEALTH 
CARE, http://wpso.dmhc.ca.gov/regulations/ (last visited Feb. 20, 2012); see About Us: An 
Introduction to CDI Operations, CAL. DEP’T OF INS., http://insurance.ca.gov/0500-about-
us/0100-cdi-introduction/ (last visited Oct. 22, 2012) [hereinafter About Us]. 
 88. Laws Relating to Health Care Plans in California, supra note 87; Minter, supra note 
63, at 37. 
 89. About Us, supra note 87; Minter, supra note 63, at 37. 
 90. CAL. INS. CODE § 10140(f) (West 2012). 
 91. Minter, supra note 63, at 38. 
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response to these shortcomings, CDI has issued regulations for 
enforcement of the IGNA.92 
These regulations begin by defining and describing key terms, 
including gender identity and gender transition.93  They next lay out four 
categories of discrimination covered by the IGNA and subject to 
regulation:  
(1) Denying, cancelling, limiting or refusing to issue or renew an 
insurance policy on the basis of an insured’s or prospective 
insured’s actual or perceived gender identity, or for the reason that 
the insured or prospective insured is a transgender person; 
(2) Demanding or requiring a payment or premium that is based in 
whole or in part on an insured’s or prospective insured’s actual or 
perceived gender identity, or for the reason that the insured or 
prospective insured is a transgender person; 
(3) Designating an insured’s or prospective insured’s actual or 
perceived gender identity, or the fact that an insured or prospective 
insured is a transgender person, as a preexisting condition for 
which coverage will be denied or limited; or 
(4) Denying or limiting coverage, or denying a claim, for services 
including but not limited to the following, due to an insured’s 
actual or perceived gender identity or for the reason that the 
insured is a transgender person: 
(A) Healthcare services related to gender transition if coverage 
is available for those services under the policy when the 
services are not related to gender transition, including but not 
limited to hormone therapy, hysterectomy, mastectomy; or 
(B) Any healthcare services that are ordinarily or exclusively 
available to individuals of one sex when the denial or 
limitation is due only to the fact that the insured is enrolled as 
belonging to the other sex or has undergone, or is in the 
process of undergoing, gender transition.94 
 
These comprehensive and detailed regulations provide clear guidance 
about prevalent discriminatory practices against transgender people.95  
Each of the four provisions of the CDI regulations specifically explains 
which existing insurance practices are foreclosed by the IGNA and by 
 
 92. CAL. CODE REGS. tit. 10 § 2561.2 (2012). 
 93. Id. 
 94. Id. 
 95. Id. 
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CDI’s enforcement of that bill.96  The legislation itself covers “actual and 
perceived gender identity” through reference to the Penal Code’s definition 
of “sex.”97  CDI’s decision to enumerate “actual and perceived gender 
identity” in each of the four CDI provisions clarifies what the IGNA sought 
to accomplish.98  The CDI regulations were filed with the California 
Secretary of State on August 3, 2012, and went into effect on September 2, 
2012.99  These regulations are a definitive step in the right direction but it is 
not yet possible to tell how successful they will be.  
IV. PATIENT PROTECTION AND AFFORDABLE CARE ACT 
OF 2010 
The 2010 ACA legislation is potentially an important advancement for 
transgender healthcare.  ACA is the most comprehensive change to 
healthcare in the U.S. since Medicare was enacted in 1965.100  Three of its 
most sweeping provisions will directly affect transgender patients’ access 
to healthcare generally and potentially will affect trans patients’ access to 
gender-confirming and gender-incongruent care as well.101  To understand 
why the ACA is the appropriate vehicle for gender nondiscrimination 
protections in healthcare provisions, a basic understanding of the scope and 
limitations as they relate to transgender patients of the ACA is necessary. 
A.  SCOPE AND LIMITATIONS OF AFFORDABLE CARE ACT 
There are four basic provisions of the ACA that are applicable to 
evaluating whether or not the ACA will effectively provide transgender 
insureds with the care they need.  First, the ACA prohibits exclusion from 
health insurance on the basis of preexisting conditions.102  Second, the 
ACA mandates coverage of essential health benefits.103  Third, the ACA 
has both individual and provider nondiscrimination provisions.104  Finally, 
through its “individual mandate,” the ACA will change the existing 
healthcare cost-shifting framework.105 
 
 96. CAL. CODE REGS. tit. 10 § 2561.2 (2012). 
 97. A.B. 1586, supra note 7. (“‘Sex’ as used in this section shall have the same meaning 
as ‘gender,’ as defined in Section 422.56 of the Penal Code.”); CAL. PENAL CODE § 
422.56(c) (West 2012) (“‘Gender’ means sex, and includes a person’s gender identity and 
gender expression. ‘Gender expression’ means a person’s gender-related appearance and 
behavior whether or not stereotypically associated with the person’s assigned sex at birth.”). 
The CDI regulations also include definitions of “actual gender idenity,” “perceived gender 
identity,” “transgender,” and “gender transition.” CAL. CODE REGS. tit. 10 § 2561.1 (2012). 
 98. CAL. CODE REGS. tit. 10 § 2561.2 (2012). 
 99. CAL. CODE REGS. tit. 10 §§ 2561.1, 2561.2 (2012).   
 100. Leonhardt, supra note 1. 
 101. See infra Part IV.A.  
 102. ACA, supra note 1, at § 2704. 
 103. Id. at §§ 1302, 2707. 
 104. Id. at §§ 2706, 1557. 
 105. Id. at § 1501. 
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1. Preexisting Condition Discrimination and Health Status 
Discrimination 
First, the ACA prohibits preexisting condition exclusions or other 
discrimination based on health status.106  Transgender patients will no 
longer need to worry about being excluded from receiving health insurance 
altogether due to their transgender status.107  While this is excellent news 
for those seeking access to health insurance generally, there is no guarantee 
that the protections will extend to coverage of those preexisting conditions 
if it is determined that procedures or care is “medically unnecessary.”108  
Transgender patients have traditionally lost the battle over whether gender-
confirming care should be categorized as medically necessary.109 
2. Mandated Coverage of “Essential Health Benefits” 
Second, the ACA mandates that coverage for all individual or small 
group market health insurance packages include comprehensive coverage 
for “essential health benefits.”110  These benefits include provisions that 
could easily cover transition-related care, including mental health 
treatment, prescription drugs, preventive and wellness services, and chronic 
disease management.111  The essential benefits listed in the ACA are not 
exhaustive.112  The Secretary of Health and Human Services (HHS) is 
responsible for defining essential benefits beyond those enumerated in the 
statute.113  The essential health benefits will be limited by what has already 
been considered “essential” in existing health plans: “[t]he Secretary shall 
ensure that the scope of the essential health benefits under [section 1302] is 
equal to the scope of benefits provided under a typical employer plan.”114  
The Secretary of Labor is to make that determination herself by conducting 
“a survey of employer-sponsored coverage to determine the benefits 
typically offered by employers.”115  As discussed above, most insurance 
plans on the market, both employer-sponsored and independently available, 
exclude transition-related care.116  Transgender people and their advocates 
can hope that the Secretary of Labor chooses to model the basic provisions 
of care on one or a few of the 207 companies who answered the Human 
 
 106. ACA, supra note 1, at § 2704. 
 107. See supra text accompanying notes 27–38.  
 108. See supra text accompanying notes 27–38. 
 109. Khan, supra note 9, at 411. 
 110. ACA, supra note 1, at §§ 1302, 2707. 
 111. Id. at § 1302(1). 
 112. Id. 
 113. Id. at § 1302(2). 
 114. Id. 
 115. Id. 
 116. HUMAN RIGHTS CAMPAIGN, CORPORATE EQUALITY INDEX 2012, 18, 28 
http://asp.hrc.org/documents/CorporateEqualityIndex_2012.pdf (last visited Sept. 21, 2012) 
(only 207 out of 636 employers rated by the HRC Corporate Equality Index fully cover 
transgender treatments).  
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Rights Campaign’s corporate equality index survey affirming transgender 
healthcare coverage; however, that is unlikely.117  The Secretary’s choice of 
plans will end up further entrenching the current status quo of limiting 
access to gender-confirming and gender-incongruent procedures.  
Under a framework set in an HHS bulletin last December, states will 
have some discretion to select Qualified Health Plans (QHPs) from existing 
plans in the state, including selecting their own “benchmark” plans for the 
items and services included in the essential health benefits package.118  
States were given the following options from which to select their 
benchmark plans: “[o]ne of the three largest small group plans in the state; 
[o]ne of the three largest state employee health plans; [o]ne of the three 
largest federal employee health plan options; [or t]he largest HMO plan 
offered in the state’s commercial market.”119  California has already 
established its health exchange and has identified its three largest health 
plans by enrollment to serve as benchmark QHPs: Kaiser Foundation 
Health Plan, Inc., Anthem Blue Cross Life & Health Co., and Blue Cross of 
California.120  Currently none of these plans provide comprehensive 
transgender health coverage, and each has an explicit exclusion for SRS.121  
California responded to the HHS bulletin by requesting clarification 
regarding cost sharing between federal and state governments.122  The ACA 
requires states to defray the cost of state-mandated benefits in excess of 
essential health benefits for QHPs.123  A state may choose a plan that does 
not include all of that state’s existing health benefit mandates but may be 
required to pay for adding additional state-mandated health benefits 
 
 117. HUMAN RIGHTS CAMPAIGN, supra note 116. 
 118. HHS to Give States More Flexibility to Implement Health Reform, U.S. DEP’T OF 
HEALTH & HUMAN SERVS. (Dec. 16, 2011) http://www.hhs.gov/news/press/2011pres/12/ 
20111216b.html; Essential Health Benefits Bulletin, CTR. FOR CONSUMER INFO. & INS. 
OVERSIGHT (Dec. 16, 2011), http://cciio.cms.gov/resources/files/Files2/12162011/essential_ 
health_benefits_bulletin.pdf [hereinafter HHS Bulletin]. 
 119. Id. 
 120. Henry J. Kaiser Family Foundation, Establishing Health Insurance Exchanges: An 
Update on State Efforts, FOCUS ON HEALTH REFORM, 2, 4–5 (Aug. 2012), 
www.kff.org/healthreform/upload/8213.pdf; Essential Health Benefits: Illustrative List of 
the Largest Three Small Group Products by State, CTR. FOR CONSUMER INFO. & INS. 
OVERSIGHT (Jan. 31, 2012), http://cciio.cms.gov/resources/files/Files2/01272012/top_three 
_plans_by_enrollment_508_20120125.pdf.  
 121. CAL. PHYSICIANS’ SERV., SHIELD SPECTRUM PPO PLAN 2000, 59 (Jan. 1, 2012); 
KAISER FOUND. HEALTH PLAN, INC., 2012 INDIVIDUAL PLAN MEMBERSHIP AGREEMENT AND 
DISCLOSURE FORM AND EVIDENCE OF COVERAGE FOR KAISER PERMANENTE FOR INDIVIDUALS 
AND FAMILIES, 45 (Jan. 1, 2012). 
 122. Letter from Toby Douglas, Dir., Cal. Dep’t of Health Care Servs., et al., to Kathleen 
Sebelius, Sec’y of U.S. Dep’t of Health & Human Servs. (Jan. 31, 2012), 
http://www.healthexchange.ca.gov/Documents/Joint%20CA%20comment%20letter%20on
%20EHB%20to%20Sec%20Sebelius%201-30-12.pdf [hereinafter California Health Benefit 
Exchange Letter]. 
 123. HHS Bulletin, supra note 118, at 9. 
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between 2014 and 2016.124  Because each of the benchmark plans currently 
excludes SRS and none has a comprehensive transgender inclusion 
provision, these plans may further entrench trans-exclusions, 
notwithstanding the California IGNA which already suggests that trans-
exclusions are unlawful.125 
Having federally mandated essential health benefits is a step toward 
full healthcare for all Americans.  Even in California, benchmark plans are 
unlikely to include transgender healthcare.  Unfortunately, the absence of a 
transgender-inclusive benchmark plan will likely make advancements for 
transgender coverage more difficult to enact without a federal requirement 
that transgender care be covered. 
3. Individual and Provider Nondiscrimination  
Third, the ACA mandates nondiscrimination in healthcare in two 
provisions.126  The first addresses discrimination against individuals.127  
The second addresses discrimination against providers.128  The ACA 
incorporates the nondiscrimination provisions of the 1964 Civil Rights Act, 
Title IX, the ADA, the 1975 Age Discrimination Act, and section 504 of 
the 1973 Rehabilitation Act into all federally funded or supported health 
programs.129  These protections will apply to the health exchanges and to 
QHPs.130  Unfortunately, as discussed above, transgender status is not 
explicitly protected by any of these federal laws, and is expressly excluded 
from the ADA.131  The HHS Office of Civil Rights has stated that they 
believe “that Section 1557’s sex discrimination prohibition extends to 
claims of discrimination based on gender identity or failure to conform to 
stereotypical notions of masculinity or femininity and will accept such 
complaints for investigation.”132  While this assurance is of enormous 
importance at the moment, a change in administration could eliminate these 
protections without a statutory reform.  The ACA also mandates that all 
health insurance providers “shall not discriminate with respect to 
 
 124. California Health Benefit Exchange Letter, supra note 122, at 2.  
 125. See sources cited supra note 121; A.B. 1586, supra note 7. 
 126. ACA, supra note 1, at §§ 1557, 2706. 
 127. Id. at § 1557. 
 128. Id. at § 2706. 
 129. Id. at §1557(a). 
 130. ACA, supra note 1, at § 1557(a). 
 131. See supra Part II; see also Hong, supra note 5, at 112–13 (discussing interpretations 
of Title VII and Title IX regarding transgender people). 
 132. Letter from Leon Rodriguez, Dir., Health and Human Servs., Office of Civil Rights, 
to Maya Rupert, Fed. Policy Dir., Nat’l Ctr. for Lesbian Rights (Aug. 6, 2012), available at 
http://www.metroweekly.com/poliglot/HHSResponse8612.pdf. The Secretary of Housing 
and Urban Development made a similar decision, issuing proposed regulations that forbid 
discrimination on the basis of gender identity.  Equal Access to Housing in HUD 
Programs—Regardless of Sexual Orientation or Gender Identity, 76 Fed. Reg. 4194 
(proposed Jan. 24, 2011) (to be codified at 24 C.F.R. pts 5, 200, 203, 236, 570, 574, and 
982). 
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participation under the plan or coverage against any healthcare 
provider.”133  This means that, provided transition-related care is covered as 
an essential health benefit, the fact that specialists are necessary for many 
gender-confirming care procedures will not be an obstacle for transgender 
patients.134  Taken together, these protections provide trans patients with 
significant hope for security in their health care access. 
4. Cost-Shifting Framework 
When the individual mandate portion of the ACA goes into effect it 
will almost entirely eliminate the detrimental effects of the cost-shifting 
scheme that currently drives U.S. healthcare costs; without modification, 
however, it will not eliminate these burdens for trans people.135  “Cost 
shifting refers to the practice of charging insured patients a higher price for 
a given healthcare service to cover the cost of delivering that service to all 
of the patients, both insured and uninsured, seen by a given provider.”136  
For the majority of people insured after the individual mandate goes into 
effect, insurance premiums will be more directly correlated with their 
healthcare needs.137  As of 2011, the ACA requires that at least eighty 
percent of all premium dollars an insured pays the insurance company goes 
to healthcare, not to bureaucratic overhead.138  Cost shifting has meant that 
trans insureds pay into an insurance system so that other patients can 
receive care that trans people also need but for which trans patients are 
often denied coverage.139  With the ACA’s new provisions, it is unclear 
whether this will change for trans-related healthcare needs, especially for 
gender-incongruent treatments or hormone therapies that are available to 
nontrans people but which are restricted for trans people.140  It will be a test 
of the ACA’s efficacy whether cost provisions have a positive effect on 
trans insureds. 
B.  AFFORDABLE CARE ACT AS A VEHICLE FOR FEDERAL EXPANSION OF 
COVERAGE REGARDLESS OF GENDER 
Explicitly protecting access to preventative care and maintenance care 
for all Americans without allowing the gender identity of the insured to 
affect their receipt of care will serve the ACA’s purpose of reducing 
uninsured individuals in America, expanding coverage, and reducing 
 
 133. ACA, supra note 1, at § 2706(a). 
 134. Id. 
 135. Id. at § 1501. 
 136. Gorton, supra note 18, at 82. 
 137. A More Secure Future: What the New Health Law Means for You and Your Family, 
THE WHITE HOUSE,  http://www.whitehouse.gov/healthreform/healthcare-overview (last 
visited Sept. 23, 2012). 
 138. Id. 
 139. J. Koenig, Distributive Consequences of the Medical Model, 46 HARV. C.R.-C.L. L. 
REV. 619, n.4 (2011); Gorton, supra note 18, at 82. 
 140. See supra Part II.B.  
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costs.141  The ACA is the most obvious vehicle through which to expand 
protections like those in California for transgender patients throughout the 
country because the ACA has centralized much of healthcare’s governance 
in the federal government.142  Adding a gender nondiscrimination 
provision, similar to A.B. 1586 and accompanied by regulations similar to 
those enacted by CDI this year, to the ACA is the most sensible way to 
ensure transgender people have access to care after the insurance access 
provisions of the ACA go into effect in 2014.143  The fight for healthcare 
protections for transgender people on the federal level would be difficult, 
but that difficulty only underscores the necessity of the protections.144 
As discussed above, the ACA will mandate coverage of “essential 
healthcare” which will likely include most procedures that are frequently 
denied to transgender people because the procedures are considered 
gender-incongruent.145  The ACA’s main purpose is to increase Americans’ 
access to affordable preventative and maintenance healthcare.146  The most 
likely mechanism of this change would be on a state-by-state basis through 
the American Health Benefit Exchanges that each state is required to 
establish by January 2014.147  State-by-state changes would necessitate 
passage of an IGNA equivalent through each state legislature, which likely 
would meet with limited success.148  The fact that enacting a federal 
protective bill will be difficult does not mean that it should not be 
attempted.149  Failure itself would lead to greater awareness of the problems 
 
 141. See, e.g., The Affordable Care Act: The Impact of Health Insurance Reform on 
Health Care Consumers Before the S. Comm. on Health, Education, Labor and Pensions, 
112th Cong. (2011) (statement of Kathleen Sebelius, Secretary, Health & Human Servs.) 
available at http://www.help.senate.gov/imo/media/doc/Sebelius2.pdf. [hereinafter 
Statement of Secretary Sebelius]. 
 142. See generally ACA, supra note 1.  
 143. ACA, supra note 1, at § 1253; see also A.B. 1586, supra note 7; CAL. CODE REGS. tit. 
10 §§ 2561.1, 2561.2 (2012). 
 144. Protecting trans people through federal legislation has historically not been met with 
success.  The most visible effort to secure protections in recent years has been through the 
now eight-times-failed Employment Non-Discrimination Act.  See H.R. 3017 (111th): 
Employment Non-Discrimination Act of 2009, GOVTRACK.US, http://www.govtrack.us/ 
congress/bill.xpd?bill=h111-3017&tab=related (last visited Feb. 27, 2012) (discussing the 
history of the Employment Non-Discrimination Act which was introduced in the 103rd, 
104th, 105th, 106th, 107th, 108th, 110th, and 111th congressional sessions). 
 145. ACA, supra note 1, at § 1302(b). 
 146. See Statement of Secretary Sebelius, supra note 141.  
 147. Fact Sheet: The Affordable Care Act: Supporting Innovation, Empowering States, 
THE WHITE HOUSE, http://www.whitehouse.gov/the-press-office/2011/02/28/fact-sheet-
affordable-care-act-supporting-innovation-empowering-states (last visited Sept. 7, 2012). 
 148. Efforts to make state-by-state changes in other areas of transgender protections have 
been met with varying success.  See generally Spade, Documenting, supra note 2; Spade, 
Resisting, supra note 2.  Efforts to enact federal legislation protecting transgender people 
have also met with limited success.  See supra note 144. 
 149. There has been one notable recent success protecting transgender people on the 
federal level.  The Matthew Shepherd and James Byrd Hate Crimes Act enumerates “gender 
identity” as a protected characteristic.  Hate Crime Acts, 18 U.S.C.A. § 249 (West 2009). 
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transgender insureds face and awareness alone might lead to better 
treatment. 
V. COST OF INCLUDING GENDER-CONFIRMING AND 
GENDER-INCONGRUENT PROCEDURES IN INSURANCE 
There is a cost for every denial of treatment.150  For most denials of 
treatment that cost is negligible with respect to the cost of the procedure in 
question.  When denials become consistent realities for insureds, however, 
the cost of those denials and their appeals begin to become noticeable. 
A.  CURRENT SYSTEMIC INCONSISTENCIES FOR TRANS PEOPLE COST 
MONEY 
For every denial, there is an appeals process that the denied person can 
go through in an effort to achieve a different outcome.151  In private 
insurance markets, when a patient is denied coverage the insured receives a 
letter denying coverage.152  This letter will describe the procedure for 
appealing the denial.153  Typically the first step in an appeal is to contact 
the insurance company, provide information about the denial of coverage, 
and request a review of the denial.154  Reviewing denials takes time and 
costs the insurance company money.155  Additionally, if the review is not in 
the insured’s favor, she can appeal to a state agency like the CDI, which 
costs the state money.156  If neither of these efforts is successful, the insured 
can bring a private suit against the insurance company.157 
Transgender people who are routinely denied care for gender-
incongruent procedures are sometimes given workaround procedures from 
their insurance companies to preempt both the monetary and time costs 
associated with the appeals process for each denial.  Unfortunately, these 
workarounds, developed and implemented on an ad hoc basis, provide little 
aid or insight for those who may seek a workaround themselves.  This is 
arbitrary, unfair, and expensive: the opposite of what healthcare-provision 
ought to be.158  D, whose insurance company routinely denied his claims 
for “female” procedures was able to obtain a special code number to use 
whenever he called the company to appeal gender-incongruent procedure 
 
 150. How to Appeal a Health Insurance Denial, WALL ST. J., (Aug. 6, 2009, 11:07 AM), 
http://guides.wsj.com/health/health-costs/how-to-appeal-a-health-insurance-denial/. 
 151. Id. 
 152. Id. 
 153. Id. 
 154. Id. 
 155. Id. 
 156. Consumer Health Care Providers Guide to the Complaint Process, CAL. DEP’T OF 
INS., http://www.insurance.ca.gov/0100-consumers/0060-information-guides/0050-health/health 
careguidecomplaintprocess.cfm (last visited Sept. 23, 2012). 
 157. Cal. Civ. Code § 3428(k)(1) (West 2000). 
 158. Interview with D, in S.F., Cal. (Feb. 2, 2012). 
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denials.159  For reasons unknown to him, his insurance ID number itself 
was insufficient for the company’s coding structure and he needed to have 
a second number of equivalent length and complexity to provide them for 
each denial he received.160  The company thereby truncated D’s denial 
appeals by simply requiring him to call once, provide this number, and 
confirm the reasoning behind the number.161  Though this certainly saved 
the company money, it also left D feeling like a FedEx package.162  It was 
less efficient than if there simply were no denials for gender-incongruent 
procedures, and the company’s solution did not improve care for anyone 
else. 
The same company who held D’s insurance gave another transman, F, 
a different procedure by which to appeal his routine denials for gender-
incongruent procedures.  F did not receive a special tracking number, but 
was instead told to send all of his denial appeals inquiries through a 
specific “case manager.”163  Again, F’s denial appeals process was 
streamlined somewhat, but the cost was not minimized.164  This procedure 
required a specific employee.165  Had that person left or been unavailable, F 
might have found himself needing to launch a formal appeal, costing the 
company more money.166 
Knowing that the processes for two different men with the same 
insurance company are different, it is not hard to extrapolate the 
inconsistencies in administration across health insurers.  The ACA includes 
a “value for premium payments” provision which mandates that all 
insurance companies spend eighty percent of the premiums paid on 
treatment and limit company overhead expenditures to twenty percent of 
the premiums paid.167  Because there is a processing cost for denials, 
companies could run into trouble dealing with people who are routinely 
miscategorized and denied coverage on the basis of their medical history 
because these costs diminish the proportion of premium revenues spent on 
treatment.168 
B.  STATISTICS OF FREQUENCY OF PROCEDURES 
As discussed above, transgender patients face two different kinds of 
exclusionary treatment in healthcare: exclusions for routine medicine when 
 
 159. Interview with D, supra note 158. 
 160. Id. 
 161. Id. 
 162. Id. 
 163. Id. 
 164. Id. 
 165. Id. 
 166. Id. 
 167. ACA, supra note 1, at § 2718 (requiring insurance companies to account for non-
claims costs and to reimburse premium payers whose premium revenues have not been 
applied to claims payments but to other expenditures). 
 168. Id. 
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that care is considered gender-incongruent, and exclusions for gender-
confirming care.169  A decision to include any procedure or treatment in an 
insurance plan requires an actuarial examination of the cost implications of 
the change.170  Looking at the actual fiscal impact of covering transgender 
patients shows covering both gender-incongruent procedures and gender-
confirming care does not cost much. 
1. Preventative and Routine Care Is Accessed with Equivalent 
Frequency for Both Trans and Nontransgender Insureds 
Healthy transgender people require equivalent routine care to healthy 
nontransgender people.  For routine care, transgender insureds will not 
burden the healthcare system.  By making it easier for transmen to access 
gynecological care and for transwomen to access prostate and testicular 
care, there should be no proportionate increase in the number of general 
wellness exams doctors perform.171  Additionally, preventative healthcare 
is an important goal furthered by the ACA because by providing 
preventative medicine, the healthcare system overall experiences fewer 
high-cost emergency medical problems caused by chronic diseases.172  
Hormone therapies are prescribed and used by nontransgender people so 
frequently that hormone treatment can be considered routine care because it 
is ongoing and requires minimal interaction with doctors.173  “The potential 
economic value to be gained in better health outcomes from uninterrupted 
coverage for all Americans is estimated to be between $65 [billion] and 
$130 billion each year.”174  A study conducted in 2008 found that the cost 
to all insureds of adding hormone replacement therapy (HRT) for all 
transgender patients who desire it would be eighteen dollars per year.175  As 
the health care situation stands, “[a]bout 80% of HRT Rx costs are 
maintenance costs, currently covered on most insurance plans because the 
patient is documented as their new gender.”176  Preventive care is 
universally beneficial; even expenditures on preventive care for a group of 
 
 169. See supra Parts II, III. 
 170. Khan, supra note 9, at 398–90. 
 171. There will be an increase in doctor visits overall because more people will be insured.  
See Hendrik Schmitz, More Health Care Utilization with More Insurance Coverage? 
Evidence from a Latent Class Model with German Data, APPLIED ECONOMICS (forthcoming 
Dec. 2012) (on file with author). 
 172. ACA, supra note 1, at § 1302(b)(1)(I). 
 173. For example, from 2006-08 approximately twenty-five percent of women ages fifteen 
to forty-four were using some form of hormonal birth control on a regular basis.  William 
Mosher & Jo Jones, Use of Contraception in the United States: 1982-2008, 23 VITAL & 
HEALTH STATISTICS 29,  Aug. 2010 at 21; see also, generally Mary A. Horton, Cost of 
Transgender Health Benefits (2008), http://www.tgender.net/taw/thb/THBCost-OE2008.pdf 
[hereinafter Horton, Cost].  
 174. INST. OF MED. OF THE NAT’L ACADS., HIDDEN COSTS, VALUE LOST: UNINSURANCE IN 
AMERICA 2 (Nat’l Acads. Press ed., 2003).  
 175. Horton, Cost, supra note 173, at 7.  
 176. Id. 
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people who deviate from cultural norms and who are “typically perceived 
as less deserving of quality care” will improve healthcare outcomes across 
the board by reducing emergency medical costs.177 
2. Sex Reassignment Surgery Is Infrequently Performed and Will 
Likely Not Drastically Increase in Frequency as an Insured Benefit 
Transgender identity is a medicalized identity.178  Surgical status and 
access to ongoing medical treatment in the form of hormones and in most 
states, evidence of SRS is still required in order to change gender on 
identity documents.179  Requirements are based on the 1992 Model Law, 
which provided “that a person wanting to change their sex on their birth 
certificate should present a court order certifying that their sex has been 
changed by surgical procedure.”180  Even in the face of existing surgical 
intervention requirements to access accurate documentation, sexual 
reassignment surgeries are rarely performed.181  “Perhaps the most common 
misunderstanding is the belief that all transgender people undergo genital 
surgery as the primary medical treatment for changing gender.  In fact, 
gender confirming healthcare is an individualized treatment that differs 
according to the needs and pre-existing conditions of individual 
transgender people.”182 
There are between three and nine million trans Americans.183  While 
this number is instructive, the estimated prevalence of SRS is only 1:1000, 
or approximately 3000–9000.184  According to an analysis of surgeries 
performed in 2001, only 866 male-to-female (MTF) primary (bottom) 
surgeries were performed and only 336 female-to-male (FTM) primary 
(top) surgeries were performed.185  It has been roughly estimated that only 
 
 177. Gorton, supra note 18, at 85; INST. OF MED. OF THE NAT’L ACADS., supra note 174, at 
3 (“The burden of uncompensated (charity) care amounted to $35 billion in 2001 and is 
largely borne by taxpayers.  The public supports 75 to 85 percent [sic] of this care through 
federal, state and local government programs.”). 
 178. For extensive discussion of medicalization of trans identities, see Spade, Resisting, 
supra note 2; Harper Jean Tobin, Against the Surgical Requirement for Change of Legal 
Sex, 38 CASE W. RES. J. INT’L L. 393 (2006-07); for a more nuanced discussion of 
medicalizing gender, see generally Noa Ben-Asher, The Necessity of Sex Change: A 
Struggle for Intersex and Transsex Liberties, 29 HARV. J.L. & GENDER 51 (2006). 
 179. Spade, Documenting, supra note 2, at Appendix 1. 
 180. Id. (as of 2008 only sixteen states would grant driver’s licenses without proof of 
surgery); see also Policy Brief: Birth Certificate Gender Markers, NAT’L CTR. FOR 
TRANSGENDER EQUAL. (June 22, 2011, 10:07 PM), http://transgenderequality.wordpress.com 
/2011/06/22/policy-brief-birth-certificate-gender-markers/. 
 181. Mary A. Horton, The Incidence and Prevalence of SRS Among US Residents 3 (2008) 
http://www.tgender.net/taw/thb/THBPrevalence-OE2008.pdf [hereinafter Horton, Incidence].  
 182. Dean Spade, Medicaid Policy & Gender-Confirming Healthcare for Trans People: 
An Interview with Advocates, 8 SEATTLE J. FOR SOC. JUSTICE 497, 497 (2010). 
 183. See sources cited supra notes 5–6. 
 184. Horton, Incidence, supra note 181, at 3. 
 185. Id. at 5.  “Bottom” surgery refers to a surgical alteration of genitalia. “Top” surgery 
refers to a double mastectomy with chest reconstruction.  Id. 
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60% of FTM patients undergo any sort of bottom surgery—
hysterectomy/oophorectomy at 50%, metoidioplasty at 5%, and 
phalloplasty at 6%.186  Even at these very rough estimates, it is easy to 
appreciate the fact that not all trans people choose to undergo surgical 
procedures to alter their genitalia or other sex characteristics.  
A small portion of the discrepancy between transgender people and the 
number of SRS’s performed can be attributed to common misconceptions 
about the success rate of these procedures.  There have been 
misconceptions in both the medical and transgender communities that 
phalloplasty is not nearly as “successful” as vaginoplasty.187  This 
misconception adversely affects the ability of transmen to access 
appropriate documentation in those jurisdictions that require evidence of 
“corrected” genitalia and overshadows the overwhelmingly positive reports 
of those transmen who have had successful genital surgeries.188 
A larger portion of the discrepancy between the number of transsexual 
people in the U.S. and the number of people seeking SRS is certainly due 
to the cost of the procedures.  Typical approximate costs for some SRS 
procedures are as follows: hysterectomy, $8,500; mastectomy, $9,200; 
vaginoplasty, $6,000; phalloplasty, $40,000.189  Hysterectomies and 
mastectomies are among the most commonly performed inpatient surgeries 
already and these procedures are covered for many diagnoses.190  Other 
commonly covered, commonly performed surgeries include the following: 
coronary bypass surgery, $56,200; radical prostatectomy, $12,200; 
tonsillectomy, $2,600; appendectomy, $9,900.191 
With covered procedures, some increase in the number of SRS’s 
performed would be expected.  However, looking at San Francisco as a 
case study can assuage concerns that the cost of covering SRS will be 
prohibitively expensive.  In 2001, San Francisco became the first city to 
adopt policies that included SRS coverage for all of its employees.192  The 
 
 186. Horton, Incidence, supra note 181, at 8. 
 187. The definitions of success seem to be not only based on statistics of complications but 
on a comparison to nontransgender male penile structure and function for the constructed 
phallus.  Albert Leriche, et al., Long-Term Outcome of Forearm Flee-Flap Phalloplasty in 
the Treatment of Transsexualism, 101 BRIT. J. UROLOGY INT’L 1297, 1299 (2008) (“93% of 
the patients reported that the phalloplasty allowed them to accord their physical appearance 
with their feeling of masculinity.”).  But see, e.g., Khan, supra note 9, at 384; Spade, 
Resisting, supra note 2, at 31.  
 188. As of 2008 only sixteen states would grant driver’s licenses without proof of surgery.  
Spade, Documenting, supra note 2, at app. 1.  
 189. Healthcare Blue Book, supra note 54; Horton, Cost, supra note 173 at 2; Joshua 
Riverdale, Why Not Phalloplasty?, GENDER OUTLAW: FTM TRANSITION BLOG (Nov. 22, 
2008 4:33 pm), http://genderoutlaw.wordpress.com/2008/11/22/why-not-phalloplasty/.  
 190. Common Surgical Procedures, WEIL CORNELL MEDICAL COLLEGE, 
http://www.cornellsurgery.org/patients/health/surgery_common.html (last visited Feb. 22, 
2012). 
 191. Id.; Healthcare Blue Book, supra note 54.  
 192. Gorton, supra note 18, at 85. 
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policy only provided direct benefits to “a dozen transgender people who 
were among the 27,000 city employees of San Francisco.”193  However, by 
providing these benefits “the San Francisco experience has provided 
actuarial data demonstrating that fears about the high costs of SR[S] were 
completely unfounded—by more than an order of magnitude.”194  The San 
Francisco decision “in addition to providing direct benefits to a handful of 
people . . . provided concrete data to address future opposition to including 
SR[S] in other health plans.”195  Because in 2001 there were no insurance 
plans that covered SRS, San Francisco self-insured its employees.196  
“Between 2001 and 2004, they collected an additional $5.6 million of 
which only $186,000 was paid on 11 claims.  The actual additional cost 
during that period was less than $1 per employee per year.”197  A more 
detailed analysis of the costs associated with adding SRS to insurance 
conducted in 2008 found that the total extrapolated cost of SRS would be 
approximately $0.063/insured person/year.198 
C.  SOFTWARE EXISTS THAT AVOIDS THE GENDER QUESTION ALREADY 
As medical and insurance software becomes de rigueur, coverage and 
denials become more automated.199  In processing whether a coded 
procedure/diagnosis combination will be covered, there are a series of 
calculations and formulas that are used, some of which are gender 
specific.200  To account for the reality that gender-incongruent procedures 
are necessary and covered, some of the medical coding software would 
need to be retooled.201  An initial recoding could be as simple as adding an 
additional check for a preapproval on a patient for a specific procedure.  If, 
for example, a patient like D was denied a pap smear once, went through an 
appeal, and was granted that procedure once, there could be a flag either for 
a second round of code dealing with gender-incongruent procedures, or a 
human eye.  This would streamline the denial process, would be low cost, 
and would diminish the impact both on patients and on insurance carriers 
of repeated denials for covered claims.  The infrastructure of medical 
insurance software is growing.202  The ACA presents an opportunity to 
encourage insurance and health information efficiencies on a national level.  
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VI. CONCLUSION 
The ACA presents an opportunity for transgender people and their 
advocates to create a federal protection for access to healthcare regardless 
of gender.  The California A.B. 1586 and the CDI regulations recently 
promulgated regarding that provision constitute a well-built framework on 
which HHS and Congress should base a nondiscrimination in insurance 
policy that specifically addresses the unique concerns of transgender 
patients.  Ensuring that transgender patients have access to necessary 
gender-incongruent procedures will save insurers and the federal 
government money because insurers will not need to pay for the cost of 
denials for covered procedures.  Furthermore, as the San Francisco test case 
shows, adding SRS as a covered benefit for plans covered by the ACA will 
result in minimal cost, particularly when measured against the existing cost 
of implementing the ACA.  Transgender Americans should have their 
interests protected through enactment of a federal insurance gender 
nondiscrimination provision. 
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